logo

Aurinia Pharmaceuticals Inc (AUPH) Stock: A Year of Stock Market Dynamics

surveying

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Aurinia Pharmaceuticals Inc’s current trading price is -61.30% away from its 52-week high, while its distance from the 52-week low is -0.82%. The stock’s price range for this time frame has been between $4.85 and $12.43. The trading volume of the company’s shares in the Healthcare reached around 2.1 million for the day, which was evidently lower than the average daily volume of 2.12 million over the last three months.

The stock market performance of Aurinia Pharmaceuticals Inc has been fairly unsteady. Over the last year, the company’s stock hit its highest at $12.43 on 07/28/23, while the lowest price during the same time frame was $4.85, recorded on 04/18/24.

How Financial Performance Impacts Market Capitalization

Aurinia Pharmaceuticals Inc (AUPH) has experienced a quarterly decline of -38.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 695.62M and boasts a workforce of 300 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 7.09, with a change in price of -4.23. Similarly, Aurinia Pharmaceuticals Inc recorded 2,154,716 in trading volume during the last 100 days, posting a change of -46.79%.

How AUPH’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for AUPH stands at 0.26. Similarly, the long-term debt-to-equity ratio is also 0.22.

AUPH Stock Stochastic Average

Aurinia Pharmaceuticals Inc’s raw stochastic average for the past 50 days is currently at 2.64%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 14.29%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 17.26% and 25.40%, respectively.

AUPH Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -46.50%. However, over the last six months, the performance has been stronger by -38.65%. The price of AUPH decreased -7.14% over the last 30 days. And in the last five days, it has fallen by -5.31%.